We are live on ! Find out more
PALI icon

Palisade Bio
PALI

21 hedge funds and large institutions have $1.7M invested in Palisade Bio in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

40% more funds holding

Funds holding: 15 → 21 (+6)

0% more ownership

Funds ownership: 0.01% → 0.01% (+0%)

16% less capital invested

Capital invested by funds: $2.03M → $1.7M (-$333K)

Holders
21
Holders Change
+6
Holders Change %
+40%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
6
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
+$778K
2
Renaissance Technologies
Renaissance Technologies
New York
+$189K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$85.6K
4
SIG
Sargent Investment Group
Maryland
+$57.7K
5
Northern Trust
Northern Trust
Illinois
+$54.2K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$47K
2
HighTower Advisors
HighTower Advisors
Illinois
-$44K
3
Citadel Advisors
Citadel Advisors
Florida
-$28K
4
BlackRock
BlackRock
New York
-$14K

PALI Hedge Fund Activity: Q4 2021 in Review

21 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2021, worth a combined $1.7M — down 16% from $2.03M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new PALI positions and 3 closed out — a net gain of 6 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was Altium Capital Management, opening a new position worth an estimated $778K. The largest seller was Virtu Financial, exiting entirely with an estimated $47K sold.

  • 21 institutional investors held Palisade Bio (PALI) as of Q4 2021, up from 15 in Q3 2021.
  • Funds reported $1.7M of Palisade Bio stock for Q4 2021, down 16% quarter-over-quarter.
  • 9 funds opened new Palisade Bio positions in Q4 2021 and 3 closed out, a net change of +6 holders.
  • The largest Palisade Bio buyer in Q4 2021 was Altium Capital Management, an estimated $778K added.
  • The largest Palisade Bio seller in Q4 2021 was Virtu Financial, an estimated $47K sold.

Based on aggregated 13F filings for Q4 2021.